Master Ingénierie de la santé

Parcours Biohealth engineering 1re et 2e année

Présentation
The master's program in BioHealth Engineering (BHE) provides a solid foundation for the development of
sustainable biotechnological solutions and their use in health care. Students acquire knowledge about state-
of-the-art techniques, experience in operating technological platforms and analyzing big data in the context
of human health. Graduates have the competence necessary to research and develop diagnostics, disease
prevention tools and therapies
With the rapid advance of biomedical engineering, life sciences and physical sciences have converged to create
a new discipline: biomedicine. This convergence is helping scientists to make important breakthroughs, such
as innovative tools for diseases detection and drug design and delivery, for modeling diseases progression and
drug response aiming at improving our skills in personalized medicine.
Over the past 150 years, thanks to basic and translational science, average life expectancy has increased leading
to an increased occurrence in chronic diseases. There is consequently a growing need for scientists to increase
their knowledge in multi-pathologic models in order to adjust biomedical innovations. Postgraduate recruits to
the fast-growing sector of biomedical engineering will need to bring not only their expertise in a particular eld,
but also a thorough grounding in a range of technologies and the ability to apply their knowledge and skills to
the design of new products and services.
Thus, the rst year of the Master BHE aims at teaching basic sciences (basic technical skills in biology and
chemistry, statistics, drug design and modeling, physiology, English) and initiation in innovative biomedical
engineering (DNA/membrane/cell system technologies, data training). The 1st year of the master's program in
BioHealth Engineering (BHE) consists in two terms (S7 and S8) of courses. Each term consist of approximately
30 ECTS credits. The courses presented on this page apply to studies starting in autumn 2022.
.

Admission

Conditions d'admission
The master of Health Engineering is open in initial training and continuing education. The 2nd year is accessible
on le (and / or interview) to the candidates having validated the 1st year of master of a compatible course or
else by a validation of studies or acquired according to the conditions determined by the university or training.
Public continuing education : You are in charge of continuing education :

• if you resume your studies after 2 years of interruption of studies

• or if you followed training under the continuous training regime one of the previous 2 years
• or if you are an employee, job seeker, self-employed

If you do not have the diploma required to integrate the training, you can undertake a validation of personal
and professional achievements (VAPP)
You can also consult the prices applying to the public of the continuing education (link : https://www.univ-
grenoble-alpes.fr/consulter-nos-tarifs/)

Candidature

Toutes les informations de cette page sont indicatives et n'ont pas de valeur contractuelle - Mis à jour le 19 juillet 2024
How to apply depends on your prole ? You are a student of French nationality, or you reside in the EU, or
you reside in a country not covered by the Studies in France procedure (see below), you must apply via the
ecandidat application on the dates below :

• Only the 2nd year of the Master in health engineering is in English language: application from the 1st of
th
March to the 29 of April 2024.
• You live in one of the countries below. You are therefore subject to the Studies in France procedure: online
applications entered on the Campus France site.

• The application dates are as follows: from 01 october 2023 to 15 december 2023. These dates are also
listed on the Campus France website.

• The "Studies in France" procedure only concerns students residing in one of the following 41 countries:
Algeria, Argentina, Benin, Brazil, Burkina Faso, Burundi, Cameroon, Chile, China, Colombia, Comoros, Congo
Brazzaville, South Korea , Ivory Coast, Djibouti, Egypt, United States, Gabon, Guinea, India, Indonesia,
Iran, Japan, Kuwait, Lebanon, Madagascar, Mali, Morocco, Mauritius, Mauritania, Mexico, Peru, Democratic
Republic of the Congo, Russia , Senegal, Singapore, Taiwan, Togo, Tunisia, Turkey and Vietnam.

• For more information, we invite you to consult the master of Health engineering website or the training
catalog

Public cible
Non French speaking students with a background in :

• Molecular biology, cellular biology and biotechnologies (biotechnology courses)

• Biology, biochemistry, toxicology (health-environement courses)
• Medical imaging, signal processing, informatics...(innovative medical devices courses)

This program is also open to students with a medical or pharmaceutical background. This MSc can also be
selected by french speaking students wishing to follow courses in english and to include a mobility in their 2nd
year (courses or internship).

• Students from the rst year of Master’s programme (M1) « Ingénierie de la Santé »
• Students who have validated 4 years of higher education in biology, chemistry- biology…
• Students who validated 5 years of Pharmacy studies – industrial or research track
• MD or PharmD students with a strong scientic background, students in veterinary medicine
• Students in life sciences engineering
• Other proles, after examination by the selection committee

Droits de scolarité
3500 € specic participation costs + national costs

Poursuite d'études
Health4life leads on naturally to PhD positions and/or R&D careers in world-leading industries, high-potential
start-ups, teaching hospitals and universities, where students are able to utilise their skills in collaborative
cutting-edge research and innovation projects, translating technologies into viable applications for the benet
of all.
Our multidisciplinary, two-summer school programme oers diverse perspectives in all areas of health.
Examples of prospects :

Toutes les informations de cette page sont indicatives et n'ont pas de valeur contractuelle - Mis à jour le 19 juillet 2024
 • Pursuing doctoral thesis studies (around 40% of students are doing a thesis in France or elsewhere)
• Executive in hospital and industrial teams in the health sector
• Research engineer in academia
• Creation of start-ups in the eld of engineering for health

Insertion professionnelle
Find all the information concerning the success rate at the diploma and the future of our graduates
(link: https://www.univ-grenoble-alpes.fr/formation/devenir-de-nos-diplomes/)

It is also possible to consult our resource documents From studies to employment classied by elds of
training (link:
https://prose.univ-grenoble-alpes.fr/metiers-secteurs/choisir-une-thematique-ou-un-secteur/)

Infos pratiques :

> Composante : UFR Pharmacie

> Niveau : Bac +5
> Durée : 2 ans
> Type de formation : Formation initiale / continue
> Lieu : Grenoble - La Tronche domaine de la Merci

Contacts

Responsable pédagogique
Boumendjel Ahcene
Ahcene.Boumendjel@univ-grenoble-alpes.fr

Seve Michel
Michel.Seve@univ-grenoble-alpes.fr

Guieu Valerie
Valerie.Guieu@univ-grenoble-alpes.fr

Warther David
david.warther@univ-grenoble-alpes.fr

Secrétariat de scolarité
Scolarité BHE
masterbhe@univ-grenoble-alpes.fr

Programme

Programme en cours de saisie, se référer aux UE Biotechnology of membrane and

3 ECTS
cell systems
MCCC dans les pièces à télécharger.
UE Planning and communication in
3 ECTS
science
Master 1re année
UE French as a foreign language
Semestre 7

Toutes les informations de cette page sont indicatives et n'ont pas de valeur contractuelle - Mis à jour le 19 juillet 2024
UE Anglais 3 ECTS UE Anglais 3 ECTS

UE Practical aspects of biotechnology UE Application of AI for Healthcare 3 ECTS

3 ECTS
- Fundamentals
UE Artificial intelligence for OMICS 6 ECTS
UE Physiology 3 ECTS
UE BioHC School “Learning for health
6 ECTS
UE Pharmaceutical formulation 3 ECTS data"

UE Informatics and statistics 3 ECTS UE Biomedicines innovative project 6 ECTS

UE Regenerative medicine innovative

0 option(s) au choix parmi 0 6 ECTS
project
UE Biotechnology of DNA systems 3 ECTS
UE In vitro diagnostics innovative
6 ECTS
UE Data management technologies, project
3 ECTS
policies and ethics
UE Treatment and prophylaxis of
3 ECTS
UE Scientific programming in Python 3 ECTS infectious diseases
UE Health Innovation Report 3 ECTS UE Data analysis in health and
3 ECTS
environment

UE Data management technologies,

3 ECTS
policies and ethics
Semestre 8
UE Drug repositionning 3 ECTS
UE Introduction to drug discovery and
3 ECTS
drug design UE Ethical and societal aspects of
3 ECTS
Artificial Intelligence
UE Hackathon project 3 ECTS
UE Genetics and epigenetics of
UE Internship 12 ECTS 3 ECTS
infertility

0 option(s) au choix parmi 0 UE Internet of things and AI for Health 3 ECTS

UE Biotechnology engineering: UE Introduction to AI for Health 3 ECTS

design, experimentation and 12 ECTS
marketing UE Machine learning and Deep
3 ECTS
learning for health
UE Data challenge 6 ECTS
UE Market analysis, finance, strategy 3 ECTS
UE Image processing 6 ECTS
UE Methods and means for biohealth
6 ECTS
research

UE Neural network modelling AI for

3 ECTS
Master 2e année Health Applications

UE Biomarkers and In Vitro

Semestre 9 Diagnostics
6 ECTS

7 option(s) au choix parmi 10

UE Computer-based medicine for
chronic diseases (ESI summer school 6 ECTS
archamps) Semestre 10
UE Proteomics for health research 3 ECTS 1 option(s) au choix parmi 6
UE French as a foreign language UE Ecole BioHC (Une école au choix
6 ECTS
parmi les écoles organisées)
UE other UGA's mentions
UE Entrepreneurship essentials (EIT) 6 ECTS
UE other UGA's mentions
UE Projet Tutoré 6 ECTS
UE Innovative cell and gene therapies 6 ECTS
UE Stage EIT 18 ECTS
UE Animal experimentation 3 ECTS
UE Stage 24 ECTS 24 ECTS
UE Modeling in environmental health
UE Stage 30 ECTS
UE Micro and nanotechnologies for
3 ECTS
health

UE Pollutants and health 3 ECTS

Toutes les informations de cette page sont indicatives et n'ont pas de valeur contractuelle - Mis à jour le 19 juillet 2024